Chat with us, powered by LiveChat

Past

Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo

Held in Nashville, Tennessee, the SOT 62nd Annual Meeting and ToxExpo featured an array of scientific sessions, posters and presentations. A team of us from Lhasa attended the event, where we hosted two exhibitor-hosted sessions: Tackling ICH S1B using AOPs Supporting drug development using in silico solutions Lhasa Limited scientific posters, in date order. Poster Title: Mechanisms …

Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo Read More »

IPEC Excipients Forum 2023

We were delighted to attend the IPEC Excipients Forum 2023. Lhasa Limited Principal Application Scientist, Grace Kocks presented on the Elemental Impurities Data Sharing Initiative. Held in Lisbon, the IPEC Excipients forum brings together experts on pharmaceutical excipients from across the world.  

7th Impurities: Genotoxic, Nitrosamine & Beyond Summit

We were delighted to attend the 7th Impurities: Genotoxic, Nitrosamine & Beyond summit in Milan, Italy. In addition to focusing on N-nitrosamines, this event explored detecting and reporting genotoxic impurities, as well as recent advances, further development and future considerations towards the different types of impurities present in drugs. Lhasa Principal Scientist, Michael Burns presented …

7th Impurities: Genotoxic, Nitrosamine & Beyond Summit Read More »

The 11th International Drug Chemistry Congress

We were excited to attend the 11th International Drug Chemistry Congress! Held at the Antalya-Kemer Mirage Park Resort Hotel from March 9th – 12th, this Congress was helpful for all participants in pharmaceutical R&D and production, as well as the international pharmaceutical industry. Principal Application Scientist, Fernanda Waechter presented on nitrosamines and the Complex Nitrosamines data …

The 11th International Drug Chemistry Congress Read More »

Supporting mutagenic impurity and degradant risk assessment using an in silico approach

We recently held our first webinar of 2023, ‘Supporting mutagenic impurity and degradant risk assessment using an in silico approach’. This free-to-attend webinar featured talks from Dr. Andreas Broehl, Laboratory Head at Bayer Pharmaceuticals, and Lhasa Limited Senior Scientist, Dr. Ash Ali. In this exciting virtual event, we explored how our in silico software solution Zeneth, can …

Supporting mutagenic impurity and degradant risk assessment using an in silico approach Read More »

United States Pharmacopeia (USP) Workshop on Nitrosamine Impurities

We were excited to attend USP’s Workshop on Nitrosamine Impurities, organised by United States Pharmacopeia (USP) in collaboration with Indian Pharmaceutical Alliance (IPA). Lhasa Principal Scientist, David Ponting presented within the Toxicity Assessment session, his presentation was titled ‘Application of in silico tools (QSAR) to predict toxicity’.  

Genotoxic Impurities in Pharmaceutical Industry

We were excited to attend the Genotoxic Impurities in Pharmaceutical Industry Hybrid Conference! Held in Barcelona, Spain on the 26th and 27th of January and online, the Genotoxic Impurities in Pharmaceutical Industry conference contained case studies from large and small pharmaceutical companies. Discover the latest technical insights and discuss rapidly advancing technologies in Toxicology & …

Genotoxic Impurities in Pharmaceutical Industry Read More »

N-nitrosamines Mini Event

Lhasa Limited were thrilled to sponsor and exhibit a virtual booth at Scientific Update’s online N-nitrosamines Mini Event. Chair of AstraZeneca’s Impurity Advisory Board, Andrew Teasdale PhD spoke within the workshop, his talk was titled “N-Nitrosamines – Current status of regulations and science”. Lhasa Principal Application Scientist, Fernanda Waechter also be presented ‘How can nitrosamine risk assessments be supported by in silico systems and data sharing …

N-nitrosamines Mini Event Read More »

Sindusfarma Workshop: Risk Assessment of the presence of Nitrosamines in IFAs and Medicines

We were pleased to join Sindusfarma for an online workshop to discuss how to perform Step 1 of the Nitrosamines Risk Assessment. The objective of this workshop was to present the concepts and practical aspects on the risk assessment of the presence of nitrosamines in Active Pharmaceutical Inputs (IFAs) and Medicines, considering the publication of RDC 677/2022 and …

Sindusfarma Workshop: Risk Assessment of the presence of Nitrosamines in IFAs and Medicines Read More »